companies / cancertargetedtechnology-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-02 json
| total_raised | 1,999,9982.0M | ○ |
|---|---|---|
| founded | null | |
| hq | Pullman, Washington | |
| industry | unknown | |
| stage | null |
Cancer Targeted Technology develops small-molecule drugs that pair diagnostic imaging agents with paired therapies, with prostate cancer as the lead indication. It serves oncology programs and partners building theranostic pipelines. The integrated diagnostic-plus-therapeutic approach lets the same molecule guide and treat the disease.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-01-01 | grant | 1,999,9982.0M | null | ○ |
Apache HTTP Server, Google Analytics, Google Tag Manager, Prototype, DoubleClick Floodlight, WordPress, PHP, MySQL, apache
| fact | status | src |
|---|---|---|
| Grant, $2.0M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |